Possible Advantage of Twice-Daily 6-Mercaptopurine Dosing in Children with Acute Lymphoblastic Leukemia (ALL).
Thaddeus Y. Carson(Augusta University), Meenakshi Devidas(National Institutes of Health), Bruce Bostrom(Minnesota West Community & Technical College), Gary R. Erdmann, Beverly Bell(Children's Medical Center), Bruce M. Camitta(Medical College of Wisconsin)
Cited by 1
Related Papers
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
|Nature Genetics|2017|934
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
|Journal of Clinical Oncology|1996|920